Clinical Trial Update: Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT) [NA]

View source ↗

Summary

Clinical trial NCT03886181 evaluating the DaRT device (alpha radiation emitters) for cutaneous, mucosal, and superficial soft tissue neoplasms has been terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Mucosal Neoplasms
• Skin Cancer
• Soft Tissue Neoplasms

Drugs mentioned

• DaRT (alpha radiation emitter device)

Snippet

Sponsor: Alpha Tau Medical LTD. | Conditions: Skin Cancer, Mucosal Neoplasm of Oral Cavity | NA | Status: TERMINATED